RxDoctor Payments Data

Ajay Premkumar, MD

Adult Reconstructive Orthopaedic Surgery · Atlanta, GANPI 1194188458

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (46.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 71.2% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $45,369, more than ten times the $224 reported in 2021. Among adult reconstructive orthopaedic surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$99,488in general payments, 2019–2025

Across 179 payments — averaging $555.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$71K
  • Medacta USA, Inc.$18K
  • Stryker$4K
  • Naviswiss, Inc.$3K
  • Ortho Development Corporation$3K
  • Linkbio Corp$286
  • plus $455 from 6 others
$125,574in research payments, 2019–2025

Across 11 payments — averaging $11,416 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$126K

What the payments were for

  • Consulting fees$46,40347%
  • Travel & lodging$30,73031%
  • Food & beverage$10,35410%
  • Education$12,00012%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$99,488 in reported general payments places this provider in the 90th percentile of 23 adult reconstructive orthopaedic surgery providers in Georgia.

See all adult reconstructive orthopaedic surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$243,324
Medicare patients
265
Services billed
991

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl132$560
Ondansetron Hcl95$488
Methylprednisolone61$377
Diclofenac Sodium21$370
Meloxicam113$296
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$200
Gabapentin14$95
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$73
Amoxicillin36$51
Clindamycin Hcl13$28

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →